Added stroke drugs showed no clear overall benefit in functional independence
The review found uncertain overall results, with a possible tirofiban benefit in randomized trials.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Adding tirofiban or eptifibatide to intravenous thrombolysis did not clearly improve functional independence after acute ischemic stroke overall. Mortality and bleeding comparisons were also inconclusive. Randomized tirofiban trials suggested a possible benefit for independence, but that signal remained uncertain and needs confirmation in larger trials.
The main analysis combined randomized and observational studies. The abstract provides no estimate for the tirofiban-only randomized analysis, limiting assessment of that possible benefit.
What researchers found
Functional independence
At 90 days, added tirofiban or eptifibatide versus thrombolysis alone. Risk ratio compares likelihoods: one means equal likelihood, and the interval crosses that reference. It is not an absolute percentage-point difference.
How to read the result
The interval allows both less and more independence with the added drugs. This leaves uncertainty about the direction of the effect; a nonsignificant result does not show that the treatments are equivalent.
Bleeding findings have limits
The pooled results found no statistically significant differences in mortality or symptomatic brain bleeding. Other bleeding outcomes were also nonsignificant. That does not establish equal safety, because the estimates still allow potentially important differences.
The original publication
Safety and efficacy of adjunctive tirofiban and eptifibatide in acute ischemic stroke: A systematic review and meta-analysis.
Ali H, Shehzad R, Ahmed U et al.
J Stroke Cerebrovasc Dis · 2026
- PubMed ID
- 41500359
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.